Cargando…
Neoadjuvant immunotherapy in primary and metastatic colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is the second most common solid organ cancer. Traditional treatment is with surgery and chemotherapy. Immunotherapy has recently emerged as a neoadjuvant therapy that could change treatment strategy in both primary resectable and metastatic CRC. METHODS: A literat...
Autores principales: | Kanani, A, Veen, T, Søreide, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364874/ https://www.ncbi.nlm.nih.gov/pubmed/34694371 http://dx.doi.org/10.1093/bjs/znab342 |
Ejemplares similares
-
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
por: Veen, Torhild, et al.
Publicado: (2023) -
Histopathological Growth Pattern in Colorectal Liver Metastasis and The Tumor Immune Microenvironment
por: Zaharia, Claudia, et al.
Publicado: (2022) -
Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer
por: Zhou, Long, et al.
Publicado: (2023) -
Immunotherapy: Recent Advances and Its Future as a Neoadjuvant, Adjuvant, and Primary Treatment in Colorectal Cancer
por: Yu, Irene, et al.
Publicado: (2023) -
Combinatorial Immunotherapies for Metastatic Colorectal Cancer
por: Janssen, Eline, et al.
Publicado: (2020)